Clinical Trials Browser

Phase 2 × Leukemia, Plasma Cell × daratumumab × Clear all

NCT05054478 2021-09-23

PCL-2

Phase 2 Not yet recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell